Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierWe operate in the $1,118.0 billion Medicare market, which covers more than 68 million eligible lives as of July 2025. Our core focus is the Medicare Advantage (“MA”) market, which covers approximately 34 million Medicare eligible lives in 2025. Medicare beneficiaries may enroll in an MA plan, under which payors contract with the CMS to provide a defined range of healthcare services that are comparable to Medicare fee-for-service (“FFS”), which is also referred to as “traditional Medicare.”
In the company’s own words · 10-K filed Mar 26, 2026 · SEC EDGAR
Business segments
Q1 2026 · $400.2MThe company’s own SEC segment disclosure.
- Capitated$379.5M95%
- Health Care Other$6.9M2%
- Health Care Patient Service$6.9M2%
- Health Care Care Coordination Management Fees$6.5M2%
- Health Care Clinical Fees Insurance$263.0K0%
- Health Care Incentive Fees$110.0K0%
P3 Health Partners Inc. (PIII) reported revenue of $386M in Q1 2026 (quarter ended March 31, 2026), up 3.5% from the same quarter a year earlier. That came with net income of $1.2M (0.3% of revenue). For the full year FY2025, revenue was $1.46B (−2.8% year on year) and net income −$148M. Its largest product in 2026-Q1 was Capitated at $379M, 95% of the disclosed total, just ahead of Health Care Other at 1.7%.
Raw charts
9 series · TTMAs reported to the SEC, without any scoring.